====== Canadian Network for Advanced Interdisciplinary Methods ======

{{ ::canaim-logo.png?200|}}

The **Canadian Network for Advanced Interdisciplinary Methods (CAN-AIM)** is a Canadian national research network based in [[canada:quebec:Montreal]], [[canada:Quebec]].

Its mandate is to enhance the validity and accuracy of research on drugs’ comparative effectiveness and safety.

===== Affiliations =====

The network is made up of 48 researchers from 12 universities and research centres from 6 Canadian provinces providing complementary clinical and methodological expertise, with representation from some institutions in the [[United States of America]].((//Who We Are.// CAN-AIM. Retrieved May 14, 2022, from https://canaim.ca/who-we-are/))

==== Principal Investigators ====

^     CAN-AIM Principal Investigators     ^^^^
^ Name  ^ Specialty  ^ Affiliation  ^ Notes  ^
| [[Sasha Bernatsky]]  | [[Rheumatology]]  | [[Research Institute of the McGill University Health Centre]]  | -  |
| [[Louise Pilote]]  | [[Internal medicine]]  | [[McGill University]]  | -  |
| [[Michal Abrahamowicz]]  | [[Biostatistics]]  | [[McGill University]], [[McGill University Health Centre]]  | -  |
==== Academia ====

Member universities in the CAN-AIM network include:

  * [[Dalhousie University]]
  * [[Laval University]]
  * [[McGill University]]
  * [[Memorial University of Newfoundland]]
  * [[Queen's University]]
  * [[Université de Sherbrooke]]
  * [[University of Alabama at Birmingham]]
  * [[University of Alberta]]
  * [[University of Calgary]]
  * [[University of British Columbia]]
  * [[University of Manitoba]]
  * [[University of Montreal]]
  * [[University of Ottawa]]
  * [[University of Toronto]]
  * [[University of Waterloo]]

==== Funding ====

CAN-AIM is funded by the [[Drug Safety and Effectiveness Network]] (DSEN) through a partnership between the [[Canadian Institutes of Health Research]] (CIHR) and [[Health Canada]].((//About CAN-AIM.// CAN-AIM. Retrieved May 14, 2022, from https://archive.ph/VFbba))